Avanos Medical Inc (AVNS)

SG&A Expenses

$290.10M

TTM · Period ending: · USD

AVNS logo

AVNS SG&A Expenses

Latest reported$290.10M
AVNS TTM SG&A Expenses ($351.40M → $290.10M)
High-resolution chart · PNG

AVNS sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Avanos Medical Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
290,100,000
296,000,000
299,400,000
306,200,000
300,400,000
303,700,000
288,600,000
283,500,000
289,500,000
287,500,000
299,800,000
314,000,000
317,000,000
324,300,000
317,000,000
310,800,000
296,900,000
284,300,000
265,000,000
268,500,000
261,800,000
264,200,000
308,400,000
313,700,000
322,100,000
322,900,000
301,700,000
301,400,000
307,200,000
314,400,000
315,100,000
311,100,000
314,700,000
329,400,000
364,100,000
377,000,000
405,500,000
400,100,000
388,300,000
396,200,000
394,100,000
398,500,000
426,600,000
440,700,000
436,200,000
424,500,000
382,600,000
353,800,000
344,400,000
351,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.